Skip to main content
Livermore
Livermore
ZHEN

Prosight Management, LP

SEC CIK
0001617201
Latest filing
Aug 14, 2026

Holdings in Q3 2023

Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.

Institution overview
Positions
41
+6 vs. Q2 2023
Portfolio value
$315.5M
−$26.0M (−7.6%) vs. Q2 2023
Filed
Nov 14, 2023
SEC
Holdings of Prosight Management, LP in Q3 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
PCRXPacira BioSciences, Inc.COM1,210,377$37.1M11.8%+332,791+37.9%AddedHistory
HUMHumana IncStock65,000$31.6M10.0%+9,900+18.0%AddedHistory
LKFTLakefront Biotherapeutics NVSPON ADR730,207$25.2M8.0%+312,707+74.9%AddedHistory
MGTXMeiraGTx Holdings plcCOM4,078,804$20.0M6.3%00.0%UnchangedHistory
KURAKura Oncology, Inc.COM1,932,456$17.6M5.6%+589,097+43.9%AddedHistory
BCRXBiocryst Pharmaceuticals IncCOM2,408,135$17.0M5.4%−91,865−3.7%ReducedHistory
ORICOric Pharmaceuticals, Inc.COM2,579,802$15.6M4.9%−181,666−6.6%ReducedHistory
MDTMedtronic plcStock150,000$11.8M3.7%+90,000+150.0%AddedHistory
ABCLAbCellera Biologics Inc.COM2,446,000$11.3M3.6%−104,000−4.1%ReducedHistory
MIRMMirum Pharmaceuticals, Inc.COM353,508$11.2M3.5%−321,492−47.6%ReducedHistory
NBIXNeurocrine Biosciences IncStock80,000$9.00M2.9%−90,000−52.9%ReducedHistory
NARIInari Medical, Inc.Stock130,000$8.50M2.7%+11,316+9.5%AddedHistory
INSPInspire Medical Systems, Inc.COM40,000$7.94M2.5%+40,000NewHistory
OPCHOption Care Health, Inc.COM NEW220,000$7.12M2.3%−15,780−6.7%ReducedHistory
QDELQuidelOrtho CorpCOM85,000$6.21M2.0%−25,468−23.1%ReducedHistory
PRTAProthena Corp Public Ltd CoSHS126,202$6.09M1.9%+6,202+5.2%AddedHistory
NSTGNS Wind Down Co., Inc.COM3,446,274$5.93M1.9%+1,446,274+72.3%AddedHistory
DXCMDexcom IncCOM62,421$5.82M1.8%+62,421NewHistory
KZRKezar Life Sciences, Inc.COM4,770,799$5.68M1.8%+118,879+2.6%AddedHistory
CNCCentene CorpStock80,000$5.51M1.7%−115,670−59.1%ReducedHistory
UHSUniversal Health Services IncCL B40,890$5.14M1.6%+40,890NewHistory
ADCTADC Therapeutics SASHS5,402,041$4.85M1.5%−181,859−3.3%ReducedHistory
TDOCTeladoc Health, Inc.COM250,000$4.65M1.5%+173,100+225.1%AddedHistory
MASIMasimo CorpCOM40,000$3.51M1.1%+40,000NewHistory
LENZLENZ Therapeutics, Inc.COM1,337,826$3.32M1.1%−362,174−21.3%ReducedHistory
IRTCiRhythm Holdings, Inc.COM35,000$3.30M1.0%−1,030−2.9%ReducedHistory
PENPenumbra IncCOM13,500$3.27M1.0%+13,500NewHistory
STTKShattuck Labs, Inc.COM2,123,000$3.23M1.0%+13,380+0.6%AddedHistory
DSGNDesign Therapeutics, Inc.COM1,203,745$2.84M0.9%+1,203,745NewHistory
BBSIBarrett Business Services IncCOM21,387$1.93M0.6%+21,387NewHistory
CMPXCompass Therapeutics, Inc.COM935,157$1.84M0.6%−148,840−13.7%ReducedHistory
ALKSAlkermes plc.SHS65,000$1.82M0.6%−82,554−55.9%ReducedHistory
LBPHLongboard Pharmaceuticals, Inc.COM321,154$1.79M0.6%−413,743−56.3%ReducedHistory
NUVBNuvation Bio Inc.COM CL A1,050,000$1.41M0.4%−50,000−4.5%ReducedHistory
AGLagilon health, inc.COM79,076$1.40M0.4%−20,924−20.9%ReducedHistory
BMEABiomea Fusion, Inc.COM94,817$1.30M0.4%+94,817NewHistory
CHEChemed CorpCOM2,500$1.30M0.4%+2,500NewHistory
EOLSEvolus, Inc.COM126,982$1.16M0.4%+126,982NewHistory
ZYMEZymeworks Inc.COM106,405$674.6K0.2%+106,405NewHistory
ERASErasca, Inc.COM264,710$521.5K0.2%−1,292,660−83.0%ReducedHistory
ELUTElutia Inc.CL A COM25,594$36.6K<0.1%−298,831−92.1%ReducedHistory

Sold out since Q2 2023 (5)

Positions held at the end of Q2 2023 that are gone from this filing.

Positions of Prosight Management, LP sold out since Q2 2023
SecurityClassShares in Q2 2023Value in Q2 2023% of portfolio in Q2 2023History
UNHUnitedHealth Group IncStock15,000$7.21M2.1%History
MRVIMaravai Lifesciences Holdings, Inc.COM CL A314,300$3.91M1.1%History
ALDXAldeyra Therapeutics, Inc.COM149,511$1.25M0.4%History
MODVModivCare IncCOM16,023$724.4K0.2%History
STLNStarling Oncology, Inc.COM455,302$250.5K0.1%History